Cyril Allouche, Principal Accounting Officer at Revance Therapeutics, Inc. (RVNC), sold 4,376 shares at $23.72 ($104K) on 2018-11-09, disclosed to the SEC on 2018-11-09.
Open-market sale of $104k RVNC by Principal Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.72 | 2,188 | $52K | 50.0% |
| 2 | $23.72 | 2,188 | $52K | 50.0% |
| Total | $23.72 avg | 4,376 | $104K | 100% |
| Filing → |
| RVNC | SELL | 2019-01-04 | $7K | — | Filing → |
| RVNC | SELL | 2018-11-21 | $10K | — | Filing → |
| RVNC | SELL | 2018-07-06 | $11K | — | Filing → |